| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.571 | 22.232 | 27.666 | 20.265 | 62.851 | 71.990 | 87.613 | 110.482 | 135.696 | 151.435 |
| Total Income - EUR | 10.571 | 22.232 | 27.666 | 20.265 | 62.852 | 71.990 | 87.613 | 110.482 | 135.696 | 151.436 |
| Total Expenses - EUR | 11.569 | 15.029 | 20.818 | 22.169 | 59.808 | 44.977 | 66.070 | 78.761 | 73.306 | 105.611 |
| Gross Profit/Loss - EUR | -998 | 7.203 | 6.849 | -1.904 | 3.044 | 27.013 | 21.543 | 31.722 | 62.390 | 45.825 |
| Net Profit/Loss - EUR | -1.315 | 6.536 | 6.019 | -2.107 | 2.415 | 26.430 | 20.932 | 30.824 | 61.296 | 41.509 |
| Employees | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Andralex Medical 2015 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 51 | 0 | 0 | 0 | 1.522 | 41.118 | 28.797 | 19.133 | 11.573 | 7.615 |
| Current Assets | 996 | 5.509 | 11.594 | 36.176 | 40.667 | 46.166 | 81.277 | 124.096 | 213.329 | 156.337 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 141 | 0 | 0 | 1.635 | 15.288 | 15.156 | 32.027 | 37.098 | 39.497 | 29.236 |
| Cash | 856 | 5.509 | 11.594 | 34.541 | 25.379 | 31.009 | 49.250 | 86.998 | 173.832 | 127.101 |
| Shareholders Funds | -1.270 | 5.279 | 11.208 | 8.896 | 11.139 | 37.358 | 57.461 | 88.463 | 149.491 | 90.741 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.317 | 230 | 386 | 27.280 | 31.050 | 49.925 | 52.613 | 54.765 | 75.410 | 73.212 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Andralex Medical 2015 Srl